Side-effects: latest news

Side-effects resources

  • Skin problems

    A rash can be a symptom of recent HIV infection. Other infections can also cause skin problems. They may also be a side-effect or allergic reaction to an anti-HIV drug. Allergic drug...

    From: Factsheets

    Information level Level 2
  • Multiple medications and drug interactions

    The more drugs you take, the greater the risk of drug interactions and side-effects. It’s important to tell your doctors and pharmacists about all the other medicines you take. An...

    From: Factsheets

    Information level Level 2
  • Lactic acidosis

    Lactic acidosis refers to a build-up of lactic acid in the blood.It is a rare but dangerous side-effect of some anti-HIV drugs – most of...

    From: Factsheets

    Information level Level 2
  • Pain

    Pain can cause emotional and mental health problems.Medication can be used in both the short and long term to control pain.Treating underlying medical problems may...

    From: Factsheets

    Information level Level 2
  • Neuropathy - nerve pain

    Peripheral neuropathy means damage to the nerves in the feet or hands.Symptoms can range from tingling to numbness to excruciating pain.There are many possible causes, including anti-HIV...

    From: Factsheets

    Information level Level 2
  • Hyperbilirubinaemia

    High levels of bilirubin in the body can be a side-effect of the anti-HIV drug atazanavir.It can make the skin or eyes more yellow, but...

    From: Factsheets

    Information level Level 2
  • Side-effects

    The booklet provides information about possible side-effects of HIV treatment. ...

    From: Booklets

    Information level Level 2
  • Changing HIV treatment

    Talk to your doctor if you are concerned about any side-effects you are experiencing.If you are having problems taking your HIV treatment, it’s important to be honest...

    From: Factsheets

    Information level Level 2
  • Nausea and vomiting

    Nausea and vomiting are possible side-effects of some HIV drugs.Most often, these side-effects will go away after a few weeks of taking the drug.Medicines called...

    From: Factsheets

    Information level Level 2
  • Diarrhoea

    Diarrhoea is common in people with HIV, particularly those with a low CD4 count.It can be caused by infection and is also a possible side-effect of some...

    From: Factsheets

    Information level Level 2
  • Side-effects checker

    A tool to help you talk to your healthcare team about any side-effects or symptoms that you have....

    From: Resources

  • Tiredness and fatigue

    Illnesses and drug side-effects can contribute to fatigue.People often report an increase in their energy levels after starting HIV treatment.A healthy balanced diet may help...

    From: Factsheets

    Information level Level 2
  • Side effects

    The most common side effects are the result of your body getting used to a new drug. After a few weeks, these side effects usually...

    From: The basics

    Information level Level 1
  • Antiretroviral drugs chart

    A one-page reference guide to the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions....

    From: Antiretroviral drugs chart

    Information level Level 1
  • Managing side-effects that interfere with eating

    Like all medicines, the drugs used to treat HIV can cause side-effects. These are most likely to occur when you first start taking a drug, but...

    From: Booklets

    Information level Level 2
  • Sleep

    Sleep is essential to physical and mental health.Anxiety, depression, drug or alcohol use, and illness can contribute to sleep problems.Simple lifestyle changes may be enough to...

    From: Factsheets

    Information level Level 2
  • Lipodystrophy

    Lipodystrophy is a side-effect of some older anti-HIV drugs which are now rarely used.Lipodystrophy includes both weight gain and weight loss.It is common for people...

    From: Factsheets

    Information level Level 2
  • Talking points: a checklist for you and your doctor

    Talking points is designed to help you talk to your doctor about HIV treatment....

    From: Resources

  • My drugs chart

    My drugs chart provides information on all the anti-HIV drugs currently licensed for use in Europe.Select your chosen drugs and drag them onto the area...

    From: My drugs chart

  • HIV treatment side-effects and mental health

    Some anti-HIV drugs can affect your emotional and mental health. Most notably, the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (Sustiva, also in the combination pill, Atripla) has...

    From: Booklets

    Information level Level 2
  • HIV treatment in women

    The evidence available suggests that HIV treatment works well for women. Unless you are pregnant, the recommendations for HIV treatment are the same for both women and...

    From: Booklets

    Information level Level 2
  • Side-effects

    Like all medications, anti-HIV drugs can cause side-effects and these can be a reason why people don’t take their treatment properly. The risk of side-effects can vary between...

    From: Booklets

    Information level Level 2
  • Effect of genetic variation on side-effects of HIV drugs

    In addition to drug levels, the other major area of research interest in pharmacogenetics is the association of human genetic variation with the incidence or...

    From: HIV treatments directory

    Information level Level 4
  • Side-effects

    Information on the side-effects associated with anti-HIV treatments and other drugs, including advice on how to cope with them, and whether treatment should be stopped...

    From: HIV treatments directory

    Information level Level 4

Side-effects features

Side-effects in your own words

Side-effects news from aidsmap

More news

Side-effects news selected from other sources

  • Taking multiple Rx drugs raises risks for aging adults with and without HIV

    Taking five or more prescription medications increases the risk of hospitalization and death in older adults infected with HIV and comparable adults without HIV. The findings of this Yale-led study highlight the potential risks of prescribing additional drugs to patients with multiple medical conditions.

    01 February 2018 | Yale News
  • AZT: The phoenix of HIV treatment

    During the last 30 years, over 15 million people have received AZT: an antiretroviral used to prevent HIV/AIDS. While it has now been replaced with other drugs in high income countries, it is still used widely in low-to-middle-income countries; this poses issues due to difficulties in detecting resistance to the drug and the side effects it carries. In this blog, author of a paper published in Infectious Disease of Poverty, Eric J. Arts, discusses his career long connection to AZT and the issues with AZT-based treatments in sub-Saharan Africa.

    24 January 2018 | BMC Blogs Network (blog)
  • Study Finds Sustiva Not Strongly Linked to Suicidal Thoughts

    But that is not necessarily the case for those with preexisting mental health problems.

    31 December 2017 | Poz
  • Marijuana Could Be Huge for Treating HIV

    From inflammation to lowering levels of the virus itself, a current study hopes to demystify pot's benefits for those living with HIV.

    17 November 2017 | VICE
  • Gilead’s Updated Version of Tenofovir Performs Well Among Blacks With HIV

    Compared with the older tenofovir, called TDF, the new one, TAF, suppressed the virus as well and offered bone, kidney and lipid benefits.

    18 October 2017 | Poz
  • HIV Regimen Switch May Contribute to Weight Gain

    According to results of a study presented at IDWeek 2017, an increase in body weight is common in HIV patients who are switched from efavirenz/tenofovir disoproxil fumarate/emtricitabine (EFV/TDF/FTC) to an integrase strand transfer inhibitor.

    09 October 2017 | Monthly Prescribing Reference
  • BHIVA response to BMJ article on ART in pregnant women living with HIV

    We do not support recommendations of "ART in pregnant women living with HIV: a clinical practice guideline" (BMJ, 11/9/17). Other systematic reviews and numerous observational studies show tenofovir to be safe in HIV in pregnancy.

    25 September 2017 | BHIVA
  • New recommendations aim to help pregnant women with HIV make informed choices

    New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

    12 September 2017 | EurekAlert
  • New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

    Napo Pharmaceuticals, Inc., and Jaguar Animal Health, Inc. (Jaguar), announced today the results of a supplemental analysis of the long-term trial of crofelemer (Mytesi®) in patients with chronic HIV-related diarrhea. The analysis revealed a mean decrease of over 70 percent in diarrhea episodes versus baseline and over 50 percent of patients with complete resolution of their diarrhea.

    27 July 2017 | Napo Pharmaceuticals press release
  • Medicine information leaflets 'too scary', say experts

    A more balanced view of the benefits and potential side effects is being called for in a report.

    20 June 2017 | BBC Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.